VirTrial Expands Internationally with a Fully Scalable Global Telemedicine Platform and a 31 Country Network of Virtual Trial Capable Research Sites
Summary
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--VirTrial today announced its international expansion with a newly appointed International Director of Business Development, a network of virtual trial capable research sites across 31 countries, policies supporting GDPR compliance, and product enhancements that support language translation into any left to right reading language. Recognizing the need to support VirTrial’s customers around the globe, Emil Hoeck has been named International Director of Business Development and will be based in Denmark. VirTrial’s Virtual Care Management (VCM) platform is HIPAA, HITECH and Privacy Shield Compliant and VirTrial has implemented policies to support GDPR compliance. “Clinical research requires collaboration at a global level and the ability to recruit a diverse representation of patients from around the world,” said Mark Hanley, VirTrial CEO. VirTrial is a telemedicine company providing a stable, long-standing virtual care management (VCM) platform to transform the clinical trial industry.